Uttam Yashwant Patil
Chief Executive Officer bei ABVC BIOPHARMA, INC.
Profil
Uttam Yashwant Patil is currently holding three positions as Chief Executive Officer at ABVC BioPharma, Inc., Chief Operating & Scientific Officer at Biokey, Inc., and Manager-Research & Development at Rgene Corp.
Patil holds a doctorate degree from National Tsing-Hua University and undergraduate and graduate degrees from the University of Pune.
Aktive Positionen von Uttam Yashwant Patil
Unternehmen | Position | Beginn |
---|---|---|
ABVC BIOPHARMA, INC. | Chief Executive Officer | 23.06.2023 |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Chief Operating Officer | 01.05.2023 |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Rgene Corp. operates as an investment holding American company. | Chief Tech/Sci/R&D Officer | 01.05.2023 |
Ausbildung von Uttam Yashwant Patil
National Tsing-Hua University | Doctorate Degree |
University of Pune | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ABVC BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA. | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Rgene Corp. operates as an investment holding American company. | Finance |